Previous Page  2 / 12 Next Page
Information
Show Menu
Previous Page 2 / 12 Next Page
Page Background

Notes:

Page 92

Addiction Therapy 2016

October 03-05, 2016

Volume 7, Issue 5(Suppl)

J Addict Res Ther

ISSN:2155-6105 JART, an open access journal

conferenceseries

.com

October 03-05, 2016 Atlanta, USA

5

th

International Conference and Exhibition on

Addiction Research & Therapy

Tracy L Hellem, J Addict Res Ther 2016, 7:5(Suppl)

http://dx.doi.org/10.4172/2155-6105.C1.028

What does the hamilton depression rating scale measure in methamphetamine users?

Tracy L Hellem

Montana State University College of Nursing, USA

T

he Hamilton Depression Rating Scale (HAMD) is widely used in studies to measure change in the severity of depression.

There are reports of established reliability and validity of the HAMD in both inpatient and outpatient psychiatric patients.

However, there are no published psychometric studies of the HAMD in a methamphetamine using population. Given that

the symptoms of depression and intoxication or withdrawal from methamphetamine overlap, it is possible that the HAMD

does not measure severity of depression in individuals who use methamphetamine. Thus, we are conducting a psychometric

evaluation of the HAMD in methamphetamine users with and without depression. This evaluation is currently underway, and

we anticipate having results in 6-8 weeks.

Biography

Tracy L Hellem completed the PhD program at the University of Utah’s College of Nursing in 2015. She has worked with methamphetamine users with comorbid

depression for 5 years. She has authored 14 manuscripts of systematic reviews, clinical trials and magnetic resonance spectroscopy studies. Dr. Hellem is an

Assistant Professor at Montana State University’s College of Nursing where she conducts a clinical trial of comorbid depression and anxiety among individuals

who use methamphetamine.

tracy.hellem1@montana.edu